Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life.
    Benzinga,  Biotechnology,  Health,  Nature,  Regenerative Medicine

    Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    June 15, 2022 /

    Originally Published on Benzinga Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life. The global regenerative medicine market  is estimated to reach $6.49 billion in 2027, up 9.3% from $3.05 billion in 2019. …

    read more
    Jessica N. Abraham Comments Off on Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    You May Also Like

    Terrence DeFranco of IotaComm

    The Internet of People — How One Man’s Passion Empowers the IotaCommUnity

    October 29, 2021
    heartcore 0 1 Previously Published on Benzinga

    CXM Software Creator Just Uplisted Last Month — Here’s What You May Want To Know

    April 4, 2022
    Carnot® Compressor, National Science Foundation (NSF) and the California Energy Commission (CEC)

    Oil-free Air In, Oil-free Air Out: Solving Problems in Compression and the Environment

    December 14, 2021
  • What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?
    Business,  Benzinga,  Biotechnology,  Finance,  Health

    What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    September 8, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) — the company formerly known as Cytocom (NASDAQ: CBLI) — recently uplisted to the Nasdaq in lieu of earlier acquisitions involving Cleveland BioLabs and ImQuest Life Sciences, Inc. Last week, the company provided an update on its integration of ImQuest and its plans going forward.  According to Statera, preclinical testing is underway in the screening of second-generation immune therapies using the ImQuest platform for the rapid and accurate assessment of various diseases and how the overall makeup and composition of these diseases interact. The company will look more closely…

    read more
    Jessica N. Abraham Comments Off on What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    You May Also Like

    iot, m2m, drone, fog computing, edge computing, smart home, smart city, connected home, smart transportation, wireless, big data, iot power, cloud computing, infrastructure, security, cybersecurity, manufacturing, supply chain, IIoT, industrial IoT, autonomous

    HP Aruba Empowers Smart Venues

    December 4, 2015
    Contests,Content Development, Tech News, Technology, Technology News, Content, Customer Experience,Demand,Digital Pivot,Downloads,Exclusivity,Gamification,Giveaways,Incentive-Based Selling,Interaction,Marketing,Mobile Advertising,Mobile App Development,Mobile Marketing,Niche Markets,Personalization,Popularity,Sales,Sampling,Stud,ySurvey,Talent Zoo,Technology,Testing,U,IUser Experience,UX,Compulsive Behavior,Connected Devices,Consumer Interests,Convenience,Couponing,Digital Pivote,Commerce,Exclusive Offers,Locational Shopping,Maryann Moschides,Mobile Advertising,Mobile Incentives,Personalized Experiences,Scanbury Shopper Survey,Shopper Experience,Shopping Habits,Study,Talent Zoo,Behavioral Analysis, Personality Types, Personality Traits,Technology News, DIgital Pivot, Tech, Technology News, Technology,

    5 Necessary Elements for Effective Mobile App Development

    February 9, 2016
    Oblong, Benzinga, Invest, Investing, Technology, Tech, Movie Technology, Hollywood, Team-Building, Collaboration, Productivity, Workforce Collaboration, Globalization, Data, Data Analytics, Touchscreen, Smart Devices, Smart Device Technology, Extended Screens, Workforce Engagement, Engagement, Tech, Technology, Business,

    Out of the Script “Minority Report” and into Home Offices Everywhere

    June 25, 2021
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.